Home

Pharmaids Pharmaceuticals Ltd PE Ratio

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

PE

-

Last updated on: Jan 15, 2025

Key Highlights

  • The P/E Ratio of Pharmaids Pharmaceuticals Ltd is 0 as of 15 Jan 15:30 PM .
  • The P/E Ratio of Pharmaids Pharmaceuticals Ltd changed from 89.4 on March 2022 to 0 on March 2024 . This represents a CAGR of -100.00% over 3 years.
  • The Latest Trading Price of Pharmaids Pharmaceuticals Ltd is ₹ 76.86 as of 15 Jan 16:01 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Pharmaids Pharmaceuticals Ltd

No data available

Company Fundamentals for Pharmaids Pharmaceuticals Ltd

Image

Pharmaids Pharmaceuticals Ltd

NSE: PHARMAIDSPHARMA

Share Price

₹ 76.86

-1.56 (-1.99%)

stock direction

Last updated on: Jan 15, 2025

Market Price of Pharmaids Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Pharmaids Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
14 Jan 202578.42
13 Jan 202580.02
10 Jan 202581.65
09 Jan 202583.31
08 Jan 202581.68
07 Jan 202580.08
06 Jan 202578.51
03 Jan 202576.98
02 Jan 202575.48
01 Jan 202574

BlinkX Score for Pharmaids Pharmaceuticals Ltd

Asset Value vs Market Value of Pharmaids Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Pharmaids Pharmaceuticals Ltd276.57
Sun Pharmaceuticals Industries Ltd424382
Divis Laboratories Ltd159224
Cipla Ltd116943
Dr Reddys Laboratories Ltd111588

PE Ratio of Pharmaids Pharmaceuticals Ltd Explained

``

276.57

Market cap

-11

Earnings

0.0X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Pharmaids Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Pharmaids Pharmaceuticals Ltd

No data available

* All values are in %

About Pharmaids Pharmaceuticals Ltd

  • Pharmaids Pharmaceuticals Limited, incorporated in March, 1989 at Hyderabad, Telangana are the suppliers of Quality Grade range of speciality chemicals, skin care, hospital care and generic products in the areas of Orthopedic, Neuro and Gastro etc.
  • The technical team uses quality proven chemical compounds and standard processing methods maintaining proper hygiene standards.
  • The Company is primarily engaged in business of manufacturing of Generics, Bulk Drugs in various forms like tablets, capsules, liquids and powders etc., in allopathic and herbal Ayurvedic and Natural drug formulation. Emergent Bio Naturals Limited (EBNL) was amalgamated with the Company in 2019-20 and the Scheme of Amalgamation was effective on September 27, 2019.
  • Pursuant to the Scheme, 69,05,734 Equity Shares were allotted to Shareholders of Emergent Bio Naturals Limited on November 27, 2019.

Pharmaids Pharmaceuticals Ltd News Hub

Pharmaids Pharmaceuticals to convene board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 August

Read more

2024-08-21 00:00:00

Pharmaids Pharmaceuticals reports consolidated net loss of Rs 2.68 crore in the June 2024 quarter

Net Loss of Pharmaids Pharmaceuticals reported to Rs 2.68 crore in the quarter ended June 2024 as ag

Read more

2024-08-14 00:00:00

Pharmaids Pharmaceuticals schedules board meeting

Pharmaids Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 August

Read more

2024-08-07 00:00:00

Pharmaids Pharmaceuticals AGM scheduled

Pharmaids Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company will b

Read more

2024-09-03 00:00:00

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Pharmaids Pharmaceuticals Ltd

What is the current PE Ratio of Pharmaids Pharmaceuticals Ltd?

The Current PE Ratio of Pharmaids Pharmaceuticals Ltd is 0.0 as on 15 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 15 Jan 2025.

What was the PE Ratio of Pharmaids Pharmaceuticals Ltd last year?

The PE Ratio of Pharmaids Pharmaceuticals Ltd was 0.0 last year, now the PE ratio is 0.0, showing a year-on-year growth of -%.

What does the PE Ratio of Pharmaids Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Pharmaids Pharmaceuticals Ltd is 0.0. This ratio indicates that investors are willing to pay 0.0 times the earnings per share for each share of Pharmaids Pharmaceuticals Ltd.

What is the PE Ratio Growth of Pharmaids Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Pharmaids Pharmaceuticals Ltd grew by -% whereas, the EPS ratio grew by -3.9.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions